Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma
Authors:
- Phil F ChengPCPhil F Cheng
- Olga ShakhovaOSOlga Shakhova
- Daniel S WidmerDWDaniel S Widmer
- Ossia M EichhoffOEOssia M Eichhoff
- Daniel ZinggDZDaniel Zingg
- Sandra C FrommelSFSandra C Frommel
- Benedetta BelloniBBBenedetta Belloni
- Marieke Ig RaaijmakersMRMarieke Ig Raaijmakers
- Simone M GoldingerSGSimone M Goldinger
- Raffaella SantoroRSRaffaella Santoro
- Silvio HemmiSHSilvio Hemmi
- Lukas SommerLSLukas Sommer
Open Access
- 22 February 2015
- journal article
- research article
- Published by Springer Nature in Genome Biology
- Vol. 16 (1) , 1-16
Abstract
Background: Melanoma is the most fatal skin cancer displaying a high degree of molecular heterogeneity. Phenotype switching is a mechanism that contributes to melanoma heterogeneity by altering transcription profiles for the transition between states of proliferation/differentiation and invasion/stemness. As phenotype switching is reversible, epigenetic mechanisms, like DNA methylation, could contribute to the changes in gene expression. Results: Integrative analysis of methylation and gene expression datasets of five proliferative and five invasion melanoma cell cultures reveal two distinct clusters. SOX9 is methylated and lowly expressed in the highly proliferative group. SOX9 overexpression results in decreased proliferation but increased invasion in vitro. In a B16 mouse model, sox9 overexpression increases the number of lung metastases. Transcriptional analysis of SOX9-overexpressing melanoma cells reveals enrichment in epithelial to mesenchymal transition (EMT) pathways. Survival analysis of The Cancer Genome Atlas melanoma dataset shows that metastatic patients with high expression levels of SOX9 have significantly worse survival rates. Additional survival analysis on the targets of SOX9 reveals that most SOX9 downregulated genes have survival benefit for metastatic patients. Conclusions: Our genome-wide DNA methylation and gene expression study of 10 early passage melanoma cell cultures reveals two phenotypically distinct groups. One of the genes regulated by DNA methylation between the two groups is SOX9. SOX9 induces melanoma cell invasion and metastasis and decreases patient survival. A number of genes downregulated by SOX9 have a negative impact on patient survival. In conclusion, SOX9 is an important gene involved in melanoma invasion and negatively impacts melanoma patient survival.Keywords
This publication has 57 references indexed in Scilit:
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- Treatment implications of the emerging molecular classification system for melanomaThe Lancet Oncology, 2011
- Increased methylation variation in epigenetic domains across cancer typesNature Genetics, 2011
- Use of Gene Expression and Pathway Signatures to Characterize the Complexity of Human MelanomaThe American Journal of Pathology, 2011
- Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically OrganizedCancer Cell, 2010
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor GrowthCell, 2010
- Epidemiology of invasive cutaneous melanomaAnnals of Oncology, 2009
- SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentationProceedings of the National Academy of Sciences, 2007
- Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cellsNature Genetics, 2005
- SOX9 directly regulates the type-ll collagen geneNature Genetics, 1997